The White House is preparing to launch a direct-to-consumer website for Americans to buy prescription drugs at discounted prices negotiated by the federal government.
White House press secretary Karoline Leavitt confirmed Tuesday morning on X that President Donald Trump will announce a “new ‘TrumpRx’ website” and a deal with Pfizer to lower prescription drug costs under Trump‘s “most favored nation” pricing policy.
Recommended Stories
- Louisiana sues California doctor over mail prescription of mifepristone
- Trump makes deal with Pfizer to lower drug costs
- Trump 'most favored nation' drug price negotiations extend past deadline
It is unclear what drugs will be offered on the website and whether or not it will be accessible to patients with private insurance, Medicare, or Medicaid.
The Pharmaceutical Research and Manufacturers of America, the industry’s chief lobbying group, announced on Monday that it will launch a similar platform to connect patients with manufacturer-direct purchasing programs.
Increasing access to direct-to-consumer prescription plans was a central pillar of Trump’s “most favored nation” executive order in May, which was intended to reduce U.S. drug prices in parity with other developed countries.
TRUMP MAKES DEAL WITH PFIZER TO LOWER DRUG COSTS
Americans pay three times more for brand-name prescriptions than people in other developed countries, according to a White House fact sheet published in July. The U.S. also makes up 75% of global pharmaceutical profits despite having less than 5% of the world population.
This is a developing story.